Famotidine Powder, For Suspension
Product Images NDC 68180-150

2 FDA label images from Lupin Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Famotidine (NDC 68180-150). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

93d01e19 749c 4f2e Bbdc E3eda54a9dca 01

93d01e19 749c 4f2e Bbdc E3eda54a9dca 01
Chemical structure of famotidine, depicting its molecular arrangement including sulfur, nitrogen, oxygen, and carbon atoms connected in a complex framework typical of this active pharmaceutical ingredient.*
FDA Label Image

93d01e19 749c 4f2e Bbdc E3eda54a9dca 02

93d01e19 749c 4f2e Bbdc E3eda54a9dca 02
Label for Famotidine for Oral Suspension USP 40 mg/5 mL powder for suspension, 50 mL bottle when reconstituted. The label includes dosing and reconstitution instructions, storage conditions, and is manufactured by Lupin Pharmaceuticals, Inc. The label shows NDC 68180-150-01 and states 'Rx only' with directions to shake well before each use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.